Name (Synonyms) | Correlation |
---|
Name (Synonyms) | Correlation | |
---|---|---|
D003141 | Communicable Diseases NIH | 0.09 |
D007239 | Infection NIH | 0.06 |
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
Prospective assay for SARS-CoV-2 antibody detection indirectly by immunofluorescence: SARS-CoV2 IIF method
Description: Sensitivity of the method by SARS-CoV2 ELISA compared
Measure: Sensitivity of the method by SARS-CoV2 ELISA compared Time: 8 monthsDescription: Detectability of the antibodies IgA type against SARS-CoV2 virus in the early stages of the disease.
Measure: Detectability of the antibodies IgA type against SARS-CoV2 virus Time: 8 months